| dc.contributor.author | Betts, JW | en_US |
| dc.contributor.author | Momin, HFA | en_US |
| dc.contributor.author | Phee, LM | en_US |
| dc.contributor.author | Wareham, DW | en_US |
| dc.date.accessioned | 2018-04-23T08:29:03Z | |
| dc.date.available | 2017-12-13 | en_US |
| dc.date.issued | 2018 | en_US |
| dc.date.submitted | 2018-02-26T11:23:49.218Z | |
| dc.identifier.issn | 0022-2615 | en_US |
| dc.identifier.uri | http://qmro.qmul.ac.uk/xmlui/handle/123456789/36443 | |
| dc.description.sponsorship | Investigator Initiated Research Grant from Merck Sharpe and Dohme Ltd . | en_US |
| dc.format.extent | 265 - 271 | en_US |
| dc.language.iso | en | en_US |
| dc.relation.ispartof | JOURNAL OF MEDICAL MICROBIOLOGY | en_US |
| dc.rights | For non-commercial purposes. The final version is published online https://dx.doi.org/10.1099/jmm.0.000671 | |
| dc.subject | tedizolid | en_US |
| dc.subject | glycopeptide resistance | en_US |
| dc.subject | antibiotic combinations | en_US |
| dc.title | Comparative activity of tedizolid and glycopeptide combination therapies for the treatment of <i>Staphylococcus aureus</i> infections: an <i>in vitro</i> and <i>in vivo</i> evaluation against strains with reduced susceptibility to glycopeptides | en_US |
| dc.type | Article | |
| dc.identifier.doi | 10.1099/jmm.0.000671 | en_US |
| pubs.author-url | https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000429655600013&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6a | en_US |
| pubs.issue | 2 | en_US |
| pubs.notes | Not known | en_US |
| pubs.publication-status | Published | en_US |
| pubs.volume | 67 | en_US |
